Skip to main content

Long-term Safety Profile of Bimekizumab in axSpA and PsA

Nov 18, 2024 10:30 am

Dr. Philip Mease discusses abstract 2367, presented at the 2024 ACR Convergence meeting in Washington, DC.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×